The presence of women on Prim’s Board of Directors has risen significantly in recent years, from a percentage of 14% in 2019 to 44% now. This participation means that the Company is among 10 of the listed companies that are surpassing the new parity targets established by the National Securities Market Commission (CNMV) for the […]
The Prim Group closed the 2020 financial year with a turnover of €147.3 million (-2.43%), very much in line with the €150.9 million seen the previous year and above the revised forecast made as a result of Covid-19, with the pandemic having a unique impact on the income statement for the second quarter. During the […]
Throughout our 150 years, we have prided ourselves on our ability to adapt to new situations. And this week we have once again proven that by holding our first PRIM Move-On Annual Sales Meeting, which brought together all those people who make up this company. The complicated situation caused by the COVID-19 pandemic forced us […]
The Prim Group recorded a significant improvement in sales, EBITDA and both its operating and net profits during the third quarter of this year, which enabled the company to lessen the negative impact suffered by its business during the first half of the year, as a result of Covid-19. Net turnover for the third quarter […]
Prim has approved the appointment of Fernando Oliveros as the company’s new Managing Director, who will join the company at the beginning of November. Fernando Oliveros, born in Mexico City in 1971, began his professional career with the Merck Group and then went on to join Johnson & Johnson in 2003, where he has held […]
En 2020 el Grupo PRIM ha reforzado su compromiso con la conciliación y el desarrollo profesional, personal y social de sus colaboradores/as internos/as, con la obtención del sello efr, que le acredita como Empresa Familiarmente Responsable.
The Prim Group closed the first half of 2020 with a net profit of €3.7 million and an EBITDA of over €7.1 million, resulting in downturns of 31.7% and 30.1%, respectively. Every item on the income statement was affected by the pandemic as since the declaration of the State of Alarm, the country’s health activity […]
The Prim Group closed the first quarter of 2020 with a 9.46% increase in sales, bringing its net turnover to more than €38.3 million compared to €35 million during the same period in the previous year. This growth is the result of, among other factors, the strong performance of the new product ranges introduced in […]
At its meeting today, the Board of Directors of Prim, S.A. approved a succession plan to renew the Company’s leadership. This agreement is the culmination of the Action Plan approved by the Board in its meeting on 30 January 2019, which included the advance of the succession process of the company’s chief executive. This position […]
This operation “strengthens” the Prim group’s presence in the Pharmaceutical sector and enables it to continue to enhance its growth strategy within the healthcare industry thanks to the complementary nature of both companies’ structures on an operational, distribution and sales network basis, as well as the product range. Sales in the company’s acquired Pharmaceutical and […]
